Correlation Between AbbVie and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AbbVie and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Organon Co, you can compare the effects of market volatilities on AbbVie and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Organon.

Diversification Opportunities for AbbVie and Organon

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between AbbVie and Organon is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of AbbVie i.e., AbbVie and Organon go up and down completely randomly.

Pair Corralation between AbbVie and Organon

Given the investment horizon of 90 days AbbVie Inc is expected to generate 1.02 times more return on investment than Organon. However, AbbVie is 1.02 times more volatile than Organon Co. It trades about -0.05 of its potential returns per unit of risk. Organon Co is currently generating about -0.24 per unit of risk. If you would invest  19,611  in AbbVie Inc on September 3, 2024 and sell it today you would lose (1,434) from holding AbbVie Inc or give up 7.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

AbbVie Inc  vs.  Organon Co

 Performance 
       Timeline  
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Organon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

AbbVie and Organon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AbbVie and Organon

The main advantage of trading using opposite AbbVie and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind AbbVie Inc and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios